InterVenn Biosciences Announces Start of Enrollment in Colonoscopy Study

InterVenn® Biosciences announced the start of enrollment in its prospective cohort study for early detection of colorectal cancer and adenomas.
[InterVenn® Biosciences (Business Wire, Inc.)]
Press Release
spot_img

Stay up-to-date with your field!

Subscribe for free weekly science newsletters.

Related News